ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 168 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,100,101 | -27.1% | 278,528 | -2.0% | 0.01% | -37.5% |
| Q4 2022 | $2,879,584 | +5.7% | 284,263 | +3.2% | 0.01% | 0.0% |
| Q3 2022 | $2,724,000 | -30.5% | 275,432 | -26.6% | 0.01% | -33.3% |
| Q2 2022 | $3,918,000 | -2.0% | 375,062 | -8.6% | 0.01% | +20.0% |
| Q1 2022 | $3,998,000 | -40.6% | 410,452 | -12.7% | 0.01% | -33.3% |
| Q4 2021 | $6,725,000 | -20.4% | 470,278 | +10.4% | 0.02% | -21.1% |
| Q3 2021 | $8,447,000 | +27.7% | 425,878 | +41.8% | 0.02% | +35.7% |
| Q2 2021 | $6,614,000 | +6.9% | 300,428 | +66.8% | 0.01% | 0.0% |
| Q1 2021 | $6,185,000 | – | 180,128 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |